DME/Retina Edition: Top Headlines for Week of May 6, 2024

In this edition, FDA accepts new drug application for Eluminex, most mentors in vitreoretinal subspecialty are men and more. Read the full coverage here:

FDA accepts investigational new drug application for Eluminex DME treatment

Most mentors in vitreoretinal subspecialty are men

Carotid artery stenosis linked to retinal changes in patients with diabetic retinopathy

AI-assisted technology makes retinal imaging 100 times faster, with greater contrast

FDA clears fully autonomous AI for portable diabetic retinopathy screening

References:

Das V, et al. Commun Med. 2024;doi:10.1038/s43856-024-00483-1.

Lee CY, et al. BMC Ophthalmol. 2024;doi:10.1186/s12886-024-03391-z.

Press Release

Press Release

Shah SM, et al. Demographics and productivity trends among academically affiliated female vitreoretinal specialists in the United States. Presented at: Real World Ophthalmology; April 27, 2024 (virtual meeting).